No Webinar This Week—Catch Up on 2025 Highlights!
Wednesday night is normally webinar night for us at IMA, but this week our team is taking a much-deserved break for the holidays. Catch up with some of the best webinars of the year!
Cancer Fighter: Fenbendazole and Mebendazole
Dr. Michael Turner explores benzimidazole medications—originally anti-parasitics—for their powerful anti-cancer effects on tumor growth, metabolism, and stem cells.
PACVS Research Exposes Immune Dysfunction After COVID Shots
A growing body of research identifies autoimmune mechanisms behind persistent COVID vaccine side effects, revealing antibody patterns that may explain PACVS symptoms.
Understanding Organ Donation Transplants and Brain Death: The Facts You Aren’t Told
Discover the truth about organ donation in this powerful new guide from IMA Chief Medical Officer Dr. Joseph Varon. Learn what brain death really means, how hospital protocols work, and why transparency matters.
Cancer Fighter: Ivermectin
Dr. Michael Turner explores Ivermectin’s emerging role in cancer care, from triggering apoptosis to killing cancer stem cells and boosting chemo effectiveness.
New Study Asks: Could Vaccine-Induced Viral Reactivation Trigger Autism?
Independent researcher Matthew Cormier explores whether vaccine-induced viral reactivation could trigger autism in a peer-reviewed study published in the Journal of Independent Medicine.
Preventing Cancer: The ROOT Protocols
Drs. Paul Marik and Justus Hope introduce the ROOT Protocols—regimens combining nutraceuticals and repurposed drugs to reduce cancer risk, featured in the latest edition of the Journal of Independent Medicine.
Can Treatment-Resistant Depression Be Helped by Psychedelics? New Study Is Cautiously Optimistic
A new IMA review examines psychedelic-assisted therapies for treatment-resistant depression, highlighting clinical promise alongside safety considerations.
Here’s a Thought: Your Diet Is Probably Missing Bitters
From your digestion to your disposition, bitter is the flavor of balance.
From Fringe to Focus: How Research Is Catching Up to Post-Acute COVID-19 Vaccination Syndrome (PACVS)
PACVS (Post-Acute COVID Vaccine Syndrome) is real, and the science is finally opening up. Months ago, IMA researchers broke ground. Now, another team is validating what patients have known all along.
